Hogg P J, Stenflo J, Mosher D F
Department of Clinical Chemistry, University of Lund, Malmö General Hospital, Sweden.
Biochemistry. 1992 Jan 14;31(1):265-9. doi: 10.1021/bi00116a036.
Thrombospondin is a multifunctional glycoprotein of platelet alpha-granules and a variety of growing cells. We demonstrate that thrombospondin is a slow tight-binding inhibitor of plasmin as determined by loss of amidolytic activity, loss of ability to cleave fibrinogen, and decreased lysis zones in fibrin plate assays. Stoichiometric titrations indicate that approximately 1 mol of plasmin interacts with 1 mol of thrombospondin, an unexpected result considering the trimeric nature of thrombospondin. Plasmin in a complex with streptokinase or bound to epsilon-aminocaproic acid is protected from inhibition by thrombospondin, thereby implicating the lysine-binding kringle domains of plasmin in the inhibition process. Thrombospondin also inhibits urokinase plasminogen activator, but more slowly than plasmin, stimulates the amidolytic activity of tissue plasminogen activator, and has no effect on the amidolytic activity of alpha-thrombin or factor Xa. These results, therefore, identify thrombospondin as a new type of serine proteinase inhibitor and potentially important regulator of fibrinolysis.
血小板反应蛋白是血小板α颗粒及多种生长细胞中的一种多功能糖蛋白。我们证明,通过酰胺水解活性丧失、裂解纤维蛋白原能力丧失以及纤维蛋白平板试验中裂解区减少来确定,血小板反应蛋白是纤溶酶的一种缓慢紧密结合抑制剂。化学计量滴定表明,约1摩尔纤溶酶与1摩尔血小板反应蛋白相互作用,考虑到血小板反应蛋白的三聚体性质,这是一个意想不到的结果。与链激酶形成复合物或与ε-氨基己酸结合的纤溶酶受到血小板反应蛋白抑制的保护,从而表明纤溶酶的赖氨酸结合kringle结构域参与了抑制过程。血小板反应蛋白还抑制尿激酶型纤溶酶原激活剂,但比纤溶酶抑制得更慢,刺激组织纤溶酶原激活剂的酰胺水解活性,并且对α-凝血酶或因子Xa的酰胺水解活性没有影响。因此,这些结果确定血小板反应蛋白是一种新型丝氨酸蛋白酶抑制剂,也是纤维蛋白溶解潜在的重要调节因子。